Exhaled Nitric Oxide in Asthma in Adults: The End is the Beginning?
Authors: Kostikas, K.; Minas, M.; I. Papaioannou, A.; Papiris, S.; A. Dweik, R.
Source: Current Medicinal Chemistry, Volume 18, Number 10, April 2011 , pp. 1423-1431(9)
Publisher: Bentham Science Publishers
Abstract:Approximately 20 years after the initial report of the measurement of exhaled nitric oxide (NO) in the exhaled air of humans, numerous publications have evaluated the possible applications of the fraction of exhaled NO (FeNO) in patients with asthma. The aim of the present review is to evaluate the technical issues and confounding factors related to FeNO measurements, as well as the role of FeNO in the diagnosis of asthma, the evaluation of asthmatic patients and the guidance of treatment. Several other issues, including the pursuit for “normal” and best personal values, the prediction of clinically relevant asthma outcomes and the identification of asthma phenotypes and future directions are discussed. FeNO represents the only exhaled biomarker that has reached clinical practice even in primary care settings and this review provides a critical view of the possible applications of this biomarker, both for the basic researcher and the clinician.
Keywords: Endogenous; Exhaled nitric oxide; FeNO measurements; S-nitrosothiols; airway; airway inflammation; asthma; asthma phenotypes; biomarker; chemoattractant; eosinophils; inflammation; phenotypes
Document Type: Research Article
Publication date: April 2011
- Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.